Literature DB >> 30485696

Viral Vectors for Gene Transfer.

Yong Hong Chen1, Megan S Keiser1, Beverly L Davidson1,2.   

Abstract

Viral vectors are a promising tool for effective delivery of genetic material into cells. They take advantage of the natural ability of a virus to deliver a genetic payload into cells while being genetically modified such that their ability to replicate is crippled or removed. Here, an updated overview of routinely used viral vectors, including adeno-associated viruses (AAV), retroviruses/lentiviruses, and adenoviruses (Ads), is provided, as well as perspectives on their advantages and disadvantages in research and gene therapy.
© 2018 by John Wiley & Sons, Inc. © 2018 John Wiley & Sons, Inc.

Keywords:  adeno-associated viruses; adeno-viruses; gene therapy; lentiviruses; retroviruses; viral vector

Mesh:

Year:  2018        PMID: 30485696     DOI: 10.1002/cpmo.58

Source DB:  PubMed          Journal:  Curr Protoc Mouse Biol        ISSN: 2161-2617


  32 in total

Review 1.  Considering the potential for gene-based therapy in prostate cancer.

Authors:  Justin R Gregg; Timothy C Thompson
Journal:  Nat Rev Urol       Date:  2021-02-26       Impact factor: 14.432

Review 2.  Recombinant Viral Vectors as Neuroscience Tools.

Authors:  Shih-Heng Chen; Juhee Haam; Mitzie Walker; Erica Scappini; John Naughton; Negin P Martin
Journal:  Curr Protoc Neurosci       Date:  2019-03-22

3.  Resveratrol Delivery via Gene Therapy: Entering the Modern Era

Authors:  Gurinder Singh
Journal:  Turk J Pharm Sci       Date:  2022-02-28

Review 4.  Recent advances in lentiviral vectors for gene therapy.

Authors:  Xiaoyu Wang; Cuicui Ma; Roberto Rodríguez Labrada; Zhou Qin; Ting Xu; Zhiyao He; Yuquan Wei
Journal:  Sci China Life Sci       Date:  2021-07-14       Impact factor: 6.038

Review 5.  Novel approaches for vaccine development.

Authors:  Makda S Gebre; Luis A Brito; Lisa H Tostanoski; Darin K Edwards; Andrea Carfi; Dan H Barouch
Journal:  Cell       Date:  2021-03-18       Impact factor: 41.582

Review 6.  Alzheimer's Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target.

Authors:  Meng Zhang; Zhigang Bian
Journal:  Front Neurosci       Date:  2021-05-24       Impact factor: 4.677

7.  Exosome-mediated delivery of RNA and DNA for gene therapy.

Authors:  Radha Munagala; Farrukh Aqil; Jeyaprakash Jeyabalan; Raghuram Kandimalla; Margaret Wallen; Neha Tyagi; Sarah Wilcher; Jun Yan; David J Schultz; Wendy Spencer; Ramesh C Gupta
Journal:  Cancer Lett       Date:  2021-02-18       Impact factor: 8.679

Review 8.  Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy.

Authors:  Olivia A Diaz Arguello; Hidde J Haisma
Journal:  Cancers (Basel)       Date:  2021-03-27       Impact factor: 6.639

9.  In Vivo Expression of Reprogramming Factor OCT4 Ameliorates Myelination Deficits and Induces Striatal Neuroprotection in Huntington's Disease.

Authors:  Ji-Hea Yu; Bae-Geun Nam; Min-Gi Kim; Soonil Pyo; Jung-Hwa Seo; Sung-Rae Cho
Journal:  Genes (Basel)       Date:  2021-05-10       Impact factor: 4.096

Review 10.  Planet of the AAVs: The Spinal Cord Injury Episode.

Authors:  Katerina Stepankova; Pavla Jendelova; Lucia Machova Urdzikova
Journal:  Biomedicines       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.